Shoshana Klein

1.1k total citations
37 papers, 859 citations indexed

About

Shoshana Klein is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shoshana Klein has authored 37 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Shoshana Klein's work include PI3K/AKT/mTOR signaling in cancer (9 papers), RNA Interference and Gene Delivery (6 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Shoshana Klein is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), RNA Interference and Gene Delivery (6 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Shoshana Klein collaborates with scholars based in Israel, United States and Germany. Shoshana Klein's co-authors include Alexander Levitzki, Hadas Reuveni, Frank McCormick, Yftah Tal‐Gan, Chaim Gilon, Nataly Kravchenko‐Balasha, Drora Zenvirth, Giora Simchen, Tamar Geiger and Noam Cohen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Shoshana Klein

36 papers receiving 837 citations

Peers

Countries citing papers authored by Shoshana Klein

Since Specialization

Citations

This map shows the geographic impact of Shoshana Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana Klein more than expected).

Fields of papers citing papers by Shoshana Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshana Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana Klein. The network helps show where Shoshana Klein may publish in the future.

Co-authorship network of co-authors of Shoshana Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana Klein. A scholar is included among the top collaborators of Shoshana Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana Klein. Shoshana Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer 2019 ·Proceedings of the National Academy of Sciences ·Alexander Levitzki, Shoshana Klein	13
2	Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling Networks 2018 ·Molecular Cancer Therapeutics ·Shih‐Ping Su, Efrat Flashner-Abramson, Shoshana Klein, (unknown), Rachel S. Lee, Jianmin Wu, Alexander Levitzki, Roger J. Daly	14
3	Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF 2016 ·PLoS ONE ·(unknown), Mario Lebendiker, Shoshana Klein, Maya Zigler, (unknown), Alexander Levitzki	7
4	HER2-Targeted Polyinosine/Polycytosine Therapy Inhibits Tumor Growth and Modulates the Tumor Immune Microenvironment 2016 ·Cancer Immunology Research ·Maya Zigler, Alexei Shir, (unknown), (unknown), Shoshana Klein, (unknown), Jeffrey Lau, Shang‐Fan Yu, Gabriel Mizraji, Anat Globerson Levin, Mark X. Sliwkowski, Alexander Levitzki	8
5	Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means 2013 ·PLoS ONE ·Noam Cohen, Nataly Kravchenko‐Balasha, Shoshana Klein, Alexander Levitzki	5
6	Contribution of gross chromosomal changes to HPV16-induced transformation 2011 ·Molecular BioSystems ·Nataly Kravchenko‐Balasha, Shoshana Klein, (unknown), Alexander Levitzki	2
7	Backbone Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt) 2011 ·Journal of Medicinal Chemistry ·Yftah Tal‐Gan, Mattan Hurevich, Shoshana Klein, (unknown), David M. Rosenthal, (unknown), Deborah E. Shalev, Masha Y. Niv, Alexander Levitzki, Chaim Gilon	24
8	Nucleic Acid-Based Therapeutics for Glioblastoma 2011 ·Anti-Cancer Agents in Medicinal Chemistry ·Alexei Shir, Alexander Levitzki, Ernst Wagner, Shoshana Klein, Manfred Ogris	0
9	Signal transduction therapy of cancer 2010 ·Molecular Aspects of Medicine ·Alexander Levitzki, Shoshana Klein	63
10	Amino acid starvation sensitizes cancer cells to proteasome inhibition 2010 ·IUBMB Life ·(unknown), Noam Cohen, Shoshana Klein, Nataly Kravchenko‐Balasha, Alexander Levitzki	6
11	Novel method for the synthesis of urea backbone cyclic peptides using new Alloc‐protected glycine building units 2010 ·Journal of Peptide Science ·Mattan Hurevich, Yftah Tal‐Gan, Shoshana Klein, (unknown), Alexander Levitzki, Chaim Gilon	32
12	Synthesis and structure–activity relationship studies of peptidomimetic PKB/Akt inhibitors: The significance of backbone interactions 2010 ·Bioorganic & Medicinal Chemistry ·Yftah Tal‐Gan, (unknown), Shoshana Klein, Alexander Levitzki, Chaim Gilon	19
13	Shift from Apoptotic to Necrotic Cell Death during Human Papillomavirus-induced Transformation of Keratinocytes 2009 ·Journal of Biological Chemistry ·Nataly Kravchenko‐Balasha, (unknown), Shoshana Klein, Alexander Levitzki	19
14	Optimization of Energy-Consuming Pathways towards Rapid Growth in HPV-Transformed Cells 2007 ·PLoS ONE ·(unknown), Nataly Kravchenko‐Balasha, Hannah Ben‐Bassat, Shoshana Klein, Alexander Levitzki	23
15	Targeted Cancer Therapy: Promise and Reality 2007 ·Advances in cancer research ·Shoshana Klein, Alexander Levitzki	13
16	Expression and purification of active PKB kinase from Escherichia coli 2005 ·Protein Expression and Purification ·Shoshana Klein, Tamar Geiger, (unknown), Mario Lebendiker, Anna Itkin, (unknown), Alexander Levitzki	15
17	Killing time for cancer cells 2005 ·Nature reviews. Cancer ·Shoshana Klein, Frank McCormick, Alexander Levitzki	75
18	The inhibition of Ras farnesylation leads to an increase in p27^Kip1 and G1 cell cycle arrest 2003 ·European Journal of Biochemistry ·Hadas Reuveni, Shoshana Klein, Alexander Levitzki	7
19	Switching yeast from meiosis to mitosis: double‐strand break repair, recombination and synaptonemal complex 1997 ·Genes to Cells ·Drora Zenvirth, Josef Loidl, Shoshana Klein, (unknown), Ronen Shemesh, Giora Simchen	49
20	Choose your partner: Chromosome pairing in yeast meiosis 1994 ·BioEssays ·Shoshana Klein	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact